Russia invaded Ukraine in February 2022, the industry sought advice from consultants with the hope to adopt strategies in addressing the crisis. However, advice didn’t align specifically enough with the unique challenges faced within the pharmaceutical clinical and commercial outbound supply chain and was therefore largely disregarded.
In light of the conflict, the supply chain was faced with documentation and routing issues as they struggled to get supply into Russia. Warehousing was needed to move out of Kyiv, and communication about whether a warehouse remained open wasn’t clear. The need to move from air to ground transportation added a layer of complexity in terms of documentation and customs, and this also came with an increased risk of moving cold products.
There were clinical communication difficulties, and concerns for staff as Ukraine operations were usually managed by Russia. New clinical trials and further commercialization was stopped in Russia. With clinical supplies usually flown and using different couriers than for commercial, moving them became a high-risk movement.
New strategies to address the current crisis needed to be adopted quickly, and there was a desire to understand what approach to inventory management others were taking, along with techniques and escalation mechanisms to address the changing regulatory environment.
How did BioPhorum address the lack of guidance?
With BioPhorum’s unique position to offer a space for open discussion, BioPhorum Supply Chain to Patient quickly responded by setting up a facilitated meeting to allow its members to understand how they could work together, for example, to consolidate shipments and improve end-user requirements documentation.
Members shared their specific challenges, and the mitigation they had already implemented. All agreed that clear communication was key, and individuals were able to confirm their approach aligned with others in the industry. This insight was incredibly valuable as they navigated the changing situation. It allowed them to create an industry perspective that was unique to them, something that previous consultations had been unable to provide.
The power of collaboration?
Discussion about best practices and the need for more transparency and consistency are not only relevant at a time of crisis. BioPhorum members are working to create a transparent patient-centric, end-to-end supply chain to ensure an uninterrupted supply to our patients through industry collaboration. Members can continue to build on these conversations, leveraging the knowledge they gather to create solutions for the long term. The BioPhorum platform allows space to collaborate on your industry challenges in an environment that provides the quickest route to implementing innovative solutions.